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BXSB mice spontaneously develop an autoimmune  disease characterized  by 
Coombs-positive  hemolytic  anemia,  antibodies  to  double-stranded  DNA,  and 
fatal  immune-complex  glomerulonephritis  (1).  These  mice are  unique  among 
murine  models for systemic lupus erythematosus (SLE) in that males are much 
more severely affected than  females. The male-predominant  pattern of disease 
has its genetic basis in the Y-chromosome (2), but the cellular basis for abnormal 
immunoregulation  in BXSB mice is unclear. As the disease progresses, there is 
B cell proliferation in the spleen and lymph nodes of BXSB males (3). There is 
also spontaneous polyclonal activation of B cells (4) and impaired interleukin  2 
production by cultured T  cells (5), but B and T  cell function in vivo appears to 
be normal (6). To further examine the cellular basis for autoimmunity in BXSB 
mice,  we  systematically  characterized  peripheral  blood  mononuclear  cells 
(PBMC)  from  BXSB  males  and  females  at  monthly  intervals.  We  found  a 
dramatic,  progressive increase in monocytes in BXSB males, beginning as early 
as 2 mo of age. By 6 mo, monocytes accounted for >50% of PBMC and, in some 
mice, comprised >90% of PBMC. Monocytosis does not occur in other murine 
models for SLE, suggesting that it may be a fundamental aspect of the disease of 
BXSB mice, not simply a secondary phenomenon associated with autoimmunity 
in general. 
Materials and Methods 
Mice.  BXSB mice were bred from pairs obtained from The Jackson Laboratory, Bar 
Harbor, ME. In contrast to the initial description of a 5-mo median survival for BXSB 
males (1), median survival in our colony and in other BXSB colonies is 8 mo (7). 
Cell Preparation.  Peripheral  blood (400  ~1)  was obtained  from  individual  mice  by 
retroorbital  bleeding into  heparinized  pipettes.  Cells were separated  from  plasma  by 
centrifugation, and PBMC were collected by centrifugation over Lympholyte-M (Cedar- 
lane, Ontario, Canada) and quantified using a Coulter ZBI cell counter (Coulter Electron- 
ics, Hialeah,  FL). 
Fluorescence Analysis ofPBMC Subpopulations.  PBMC were analyzed  using fluorescein- 
conjugated monoclonal  antibodies (MAb) and a fluorescence-activated  cell sorter (FACS) 
(B-D FACS  Systems,  Sunnyvale,  CA) as previously  described (8). T  and  B cells were 
quantified by staining  with rat MAb to Thy-l.2 (30-H 12) and ThB (59-9.2), respectively 
(8). In some experiments, cells also were stained  with rat MAb to Lyt-1 (53-7.1),  Lyt-2 
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(53-6.7),  and T200 (30-F11),  and, for detection of surface immunoglobulin, with rabbit 
antiserum against mouse Fab. These reagents, described previously (8), were generously 
provided by Dr. Jeffrey A. Ledbetter, Genetic Systems,  Seattle, WA. To detect Mac-l, 
PBMC (10~cells)  were incubated with 0.5 ~g of biotin-conjugated MAb to Mac-1 (from 
hybridoma TIB 128, American Type Culture Collection, Rockville, MD) and then stained 
with 0.5 ~g of avidin-fluorescein (Becton, Dickinson & Co., Mountain View, CA). Staining 
could be inhibited by unconjugated MAb to Mac-1 but not by another rat MAb of the 
same subclass (30-H 12). 
Detectiore of I-A  and  NK-I.1  Antigens.  I-A  and  NK-I.1  antigens  were  detected by 
complement-mediated cytotoxicity  using MAb to I-A  b (Litton Bionetics, Kensington, MD) 
and anti-NK-l.1  antiserum as described previously (9). Anti-H-2  b antiserum (C57BL/ 
10.D2 anti-C57BL/10) was used as a positive control. In concomitant studies, we showed 
that BXSB splenic NK activity was specifically abrogated by anti-NK-1.1  plus complement, 
demonstrating that BXSB NK cells bear NK-1.1. 
Detection of Fc Receptors.  Fc receptors were assessed  by rosette formation with IgG- 
coated sheep erythrocytes (SE) (10). Cells binding >4 SE were counted as positive. 
Assessment of Adherence and Phagocytic Capacity.  Adherent PBMC were quantified by 
overnight  culture  in  Falcon  3047  multiwell  tissue  culture  plates  (Becton  Dickinson 
Labware, Oxnard, CA).  The phagocytic capacity of the adherent cells was assessed  by 
their ability to ingest antibody-coated SE (11).  Cells containing one or more SE were 
counted as positive. 
Electron Microscopy.  For transmission electron microscopy, cells were fixed in  2.5% 
glutaraldehyde, postfixed in 1% OsO4, dehydrated in graded ethanol, and imbedded in 
Polybed 812 (Polysciences, Inc., Warrington, PA). Thin sections were stained with uranyl 
acetate and lead citrate and examined in a JOEL 100S transmission electron microscope. 
For scanning electron microscopy, ceils were placed on coverslips  coated with  1 ~g/ml 
poly-L-lysine (Sigma Chemical Co., St. Louis, MO), fixed in 3% gluteraldehyde, postfixed 
in 0.5% OsO~, and examined in a Cambridge Stereoscan S-150 scanning electron micro- 
scope. 
Cytochemistry.  Esterase activity was assessed by staining with 5% alpha naphthyl butyrate 
and 1% hexazotized pararosanilin, followed by counterstaining with Harris hematoxylin 
(12). Peroxidase activity was assessed by staining with benzidine dihydrochloride, sodium 
nitroprusside, and hydrogen peroxide, followed by counterstaining with Diff-Quik solu- 
tion (Harleco, Gibbstown, NJ) (12,  13). Normal mouse spleen cells and human peripheral 
blood leukocytes were used to provide positive controls for these stains. 
Results 
Fluorescence Analysis of PBMC Using Antilymphocyte  Antibodies.  PBMC from 22 
BXSB males and 6 age-matched BXSB females were analyzed at monthly intervals 
beginning at 2 mo of age, using MAb to ThB, Thy-l.2, and Lyt-2. These mice 
were  representative  of the  BXSB  strain,  in  that  males  developed  proteinuria 
(>100 mg/di) at 4  mo of age and reached 50%  mortality by 8 mo of age, while 
all of the females were alive without significant proteinuria at 9  too. In males, 
but not in females, there was a  marked rise in the number of PBMC beginning 
at 4-5  mo of age (Fig.  1 A) so that, by 8  mo, PBMC had increased 3-fold (P < 
0.01).  The increase in  PBMC was due solely to an increase in cells that lacked 
both T  and B cell markers (Fig.  1 D). These non-T non-B cells were significantly 
increased in males relative to females as early as 2 mo of age (399  +  108 cells/ 
mm  ~ vs. 63 _+ 24 cells/mmS), rose dramatically at 4 mo of age, and by 8 mo were 
increased 16-fold in males relative to females (P <  0.001). B cells did not increase 
(Fig.  1 B)  and  there  was a  statistically significant, although numerically small, 
reduction in circulating T  cells after 3 mo of age (Fig. 1 C). Lyt-2  ÷ and Lyt-2- T 
cells were comparably reduced (not shown). WOFSY,  KERGER,  AND  SEAMAN  BRIEF  DEFINITIVE  REPORT  631 
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FIGURE  1.  Total cells recovered from 400 pl of blood in BXSB males (1) and females (O). 
Each point represents  the mean  of individual surviving mice. (A) Total mononuclear cells, 
measured by Coulter counter. (B) Total B cells, assessed by staining with fluoresceinated anti- 
ThB. (C) Total T  cells, assessed by staining with fluoresceinated anti-Thy-l.2. (D) Total cells 
lacking B and T  cell markers. The frequency of these cells, as a percent of PBMC, is shown in 
parentheses. 
Characteristics of the Predominant PBMC Subpopulation in Adult BXSB Males.  We 
examined PBMC from six selected 8-mo-old BXSB males in which non-T non-B 
cells accounted for at  least  80%  of PBMC.  In these mice, 69-80%  of PBMC 
expressed Mac-1.  The  Mac-1 + cells were larger than the Thy-l.2  ÷ and ThB  + 
cells, as assessed by FACS analysis.  Light and electron microscopy confirmed 
that the predominant cells were larger than lymphocytes (7-9  pm diam).  On 
Wright's stain, these cells had indented nuclei, coarse linear chromatin, and pale 
blue cytoplasm (Fig. 2 A). Transmission electron microscopy demonstrated con- 
voluted nuclei, abundant cytoplasmic granules, prominent Golgi apparatus, and 
filopodia (Fig. 2B). Scanning electron microscopy revealed a ruffled surface with 
lamellapodia  (Fig.  2C).  These  features  all  are  typical  of monocytes.  Other 
characteristics  of the  predominant  PBMC  subpopulation  are  summarized  in 
Table I. In addition to Mac-l, the cells expressed the common leukocyte antigen, 
T200,  but  they lacked antigens expressed on T  cells (Thy-1,  Lyt-1,  Lyt-2), B 
cells (ThB,  Ig), and NK cells (NK-I.1).  They also lacked I-A  b.  In the selected 
mice,  49-66%  of PBMC  bore  Fc  receptors,  compared with  24-32%  in  age- 
matched females.  There  was  a  threefold  increase  in  adherent  cells  in  males 
relative to females, with a corresponding increase in the frequency of such cells 
that were capable of erythrophagocytosis (70% in males compared with 38% in 
females).  Finally,  the  predominant  PBMC  subpopulation  lacked  nonspecific 
esterase and myeloperoxidase. 
Examination  of bone  marrow  from  14  BXSB  males and  9  BXSB  females 
revealed a  slight increase in large Mac-1 + cells in males beyond 6  mo of age. 
However, all marrow elements appeared morphologically normal, and there was 
no evidence of any infiltrative or malignant process. 
Discussion 
Our studies demonstrate that autoimmunity in BXSB mice is associated with 
early, and  progressively dramatic,  monocytosis. There  is  no  such  increase in 632  WOFSY,  KERGER,  AND  SEAMAN  BRIEF  DEFINITIVE  REPORT 
FIGURE 2.  Morphology of peripheral blood leukocytes from an 8-mo-old BXSB male. (A) 
Wright's stain (× 2,000) of a blood smear showing monocytes with indented nuclei and coarse 
chromatin. (B) Transmission electron micrograph (× 7,500)  of the predominant cell type, 
demonstrating a convoluted nucleus, abundant cytoplasmic granules, prominent Golgi appa- 
ratus, and filopodia. (C) Scanning  electron micrograph (× 7,500) of the predominant cell type, 
demonstrating a  ruffled surface with lamellapodia. For comparison, a  lymphocyte from the 
same mouse is shown in (D). 
TARLE  I 
Characteristics of the Predominant Circulating Cell Type in Adult BXSB Males 
Present  Absent 
Surface antigens: T200, Mac-  1  Surface antigens: Thy- 1, Lyt-  1, Lyt-2, ThB, Ig, NK-  1.1, 1-A 
Fc receptors  Nonspecific  esterase 
Phagocytic capacity  Myeloperoxidase 
monocytes in autoimmune 10-mo-old NZB/NZW  (B/W)  females or  5-mo-old 
MRL/lpr  females  (unpublished data),  indicating  that  monocytosis does  not 
reflect murine lupus in  general, but is unique to BXSB mice. These findings 
suggest that  monocytes may contribute fundamentally to the pathogenesis of 
autoimmune disease in BXSB mice. 
Despite  the  importance of lymphocyte/macrophage interactions in  normal 
immunity, little is known about the role of the mononuclear phagocyte system 
in  the  development of autoimmunity. In  B/W  mice,  acquired  T  helper  cell 
deficiency has  been  linked to the presence of splenic macrophage suppressor 
cells (14).  In humans with SLE and other autoimmune diseases, clearance  of 
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A  similar defect develops in  B/W  and  MRL/lpr  mice (16,  17).  The current 
report is the first investigation of the mononuclear phagocyte system in BXSB 
mice. 
Theofilopoulos et al. (3) examined the distribution of lymphocyte subpopula- 
tions in 1-mo-old and 5-mo-old BXSB mice. They demonstrated proliferation of 
B  cells rather  than  monocytes in the spleen and  lymph nodes of adult  BXSB 
males. Preliminary studies in our laboratory confirm these observations, although 
we  find  a  marked  increase  in  splenic  monocytes  in  8-mo-old  BXSB  males 
(unpublished data).  Interestingly,  Theofilopoulos et  al.  reported  that  20%  of 
PBMC in  1-mo-old BXSB males, and 40% of PBMC in 5-too-old BXSB males, 
lacked T  cell and  B  cell  markers.  Our findings indicate that  these cells were 
monocytes and that monocytosis is an early event in the course of BXSB disease. 
In  normal  mice,  -90%  of circulating  monocytes produce peroxidase  (13). 
Although we found an increase in monocytes in BXSB males, we were unable to 
detect peroxidase in these cells. Either the monocytes in BXSB mice are defective 
in peroxidase production or they reflect an increase in the monocyte subset that 
normally lacks this enzyme. BXSB monocytes also  lacked nonspecific esterase. 
In  mice,  resident  macrophages  produce  nonspecific  esterase,  but  circulating 
monocytes do not (12). 
Studies of murine lupus have identified numerous immunoregulatory abnor- 
malities that could contribute to autoimmunity (1-5). Some of these are common 
to all murine models for SLE (4, 5). However, other abnormalities are associated 
with  particular  strains.  For  example,  in  MRL/lpr  mice,  T  cell  proliferation 
appears to be causally  related to the development of autoimmunity (18).  It is 
appealing to speculate that, in BXSB mice, monocyte proliferation might lead to 
autoimmune disease.  This hypothesis is supported by the early occurrence of 
monocytosis in  BXSB  males and by  the lack  of monocytosis in other  murine 
models for SLE.  Nonetheless, it is also possible that monocytosis in BXSB mice 
is a secondary phenomenon, either incidental or compensatory to autoimmunity. 
Studies designed to selectively deplete or transfer the monocytes will help clarify 
these issues. 
Summary 
Autoimmunity in BXSB mice is associated with a  progressive increase in the 
number of peripheral blood mononuclear cells (PBMC). This is due to a marked 
rise in circulating monocytes, identified by:  (a)  their appearance  on light and 
electron microscopy; (b) their surface antigenic characteristics; (c) their expression 
of Fc receptors; and (d) their capacity for phagocytosis. Among murine models 
for  systemic  lupus  erythematosus,  only  the  BXSB  strain  is  characterized  by 
monocytosis, suggesting that cells of monocytic lineage may contribute signifi- 
cantly to the pathogenesis of autoimmune disease in BXSB mice. 
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